MLPA® Kits

For a description how to create and adapt MLPA Kits, that are not available on this page, please have a look at our User Manual MLPA.

 

Import of SALSA MLPA® kit descriptions via the SEQUENCE Pilot operation "Mixes [master file] / button [Import]".

Mix
Version
Date
Region
Application
Vs. 01
19-02-2010
17q, 18q, 19q, 20q. Subtelomeric screening
Vs. 03
29-06-2011
17q, 18q, 19q, 20q. Subtelomeric screening
Vs. 03
01-12-2009
VPS13B 8q22 Cohen syndrome
Vs. 07
01-03-2013
VPS13B 8q22 Cohen syndrome
Vs. 08
05-02-2014
VPS13B 8q22 Cohen syndrome
Vs. 09
06-10-2016
VPS13B 8q22 Cohen syndrome
Vs. 03
01-12-2009
VPS13B 8q22 Cohen syndrome
Vs. 07
01-03-2013
VPS13B 8q22 Cohen syndrome
Vs. 08
05-02-2014
VPS13B 8q22 Cohen syndrome
Vs. 09
06-10-2016
VPS13B 8q22 Cohen syndrome
P323-B1 Vs.05 01-03-2013 CDK4-HMGA2-MDM2 Liposarcomas
Vs. 01
23-06-2008
22q11 22q11
Vs. 06
14-03-2012
22q11 22q11
P324-A2 Vs. 07 24-12-2012 22q11 22q11
P324-A2 Vs. 09 03-12-2015 22q11 22q11
Vs. 01
26-10-2011
OCA2 15q13 oculocutaneous albinism
Vs. 02
10-12-2011
OCA2 15q13 oculocutaneous albinism
Vs. 04
10-12-2015
OCA2 15q13 oculocutaneous albinism
Vs. 05
10-05-2017
OCA2 15q13 oculocutaneous albinism
Vs. 01
24-07-2009
LARGE, FKTN, POMT2 Walter Wahlberg Syndrome
Vs. 02
12-01-2011
LARGE, FKTN, POMT2 Walter Wahlberg Syndrome
Vs. 06
27-09-2013
LARGE, FKTN, POMT2 Walter Wahlberg Syndrome
Vs. 03
20-04-2010
IAMP21, RUNX1 ALL, iAMP21
Vs. 11
18-01-2017
iAMP21, RUNX1, ERG ALL, iAMP21
Vs. 02
05-07-2012
EYS 6q12 Retinitis Pigmentosa
Vs. 03
10-12-2012
EYS 6q12 Retinitis Pigmentosa
Vs. 05
09-12-2015
EYS 6q12 Retinitis Pigmentosa
Vs. 06
23-03-2017
EYS 6q12 Retinitis Pigmentosa
Vs. 01
08-12-2009
Xp22.33 ALL
Vs. 04
11-04-2014
Xp22.33 ALL
Vs. 07
07-10-2015
Xp22.33 ALL
Vs. 08
18-04-2017
Xp22.33 ALL
Vs. 01
05-07-2011
PCDH19 Epilepsy (EFMR)
Vs. 02
18-12-2012
PCDH19 Epilepsy (EFMR)
Vs. 03
13-09-2016
PCDH19 Epilepsy (EFMR)
Vs. 04
31-08-2017
PCDH19 Epilepsy (EFMR)
Vs. 02 10-09-2012 COL5A1 9q34.3 Ehlers-Danlos Syndrome
P331-B1 Vs. 03 13-05-2015 COL5A1 9q34.3 Ehlers-Danlos Syndrome
P331-B1 Vs. 04 06-01-2017 COL5A1 9q34.3 Ehlers-Danlos Syndrome
Vs. 02 10-09-2012 COL5A1 9q34.3 Ehlers-Danlos Syndrome
P332-B1 Vs. 03 13-05-2015 COL5A1 9q34.3 Ehlers-Danlos Syndrome
P332-C1 Vs. 04 06-01-2017 COL5A1 9q34.3 Ehlers-Danlos Syndrome
Vs. 01
15-05-2009
EP300 Rubinstein Taybi syndrome (RSTS)
Vs. 02
30-11-2010
EP300 Rubinstein Taybi syndrome (RSTS)
Vs. 05
10-12-2012
EP300 Rubinstein Taybi syndrome (RSTS)
Vs. 06
01-03-2013
EP300 Rubinstein Taybi syndrome (RSTS)
Vs. 08
05-10-2016
EP300 Rubinstein Taybi syndrome (RSTS)
Vs. 02
04-12-2009
DMRT1, CYP17A1, SRD5A2, HSD17B3 Gonadal Development Disorder
Vs. 04
14-04-2011
DMRT1, CYP17A1, SRD5A2, HSD17B3 Gonadal Development Disorder
Vs. 06
10-12-2012
DMRT1, CYP17A1, SRD5A2, HSD17B3 Gonadal Development Disorder
Vs. 07
26-08-2015
DMRT1, CYP17A1, SRD5A2, HSD17B3 Gonadal Development Disorder
Vs. 08
14-04-2011
IKZF1, PAX5, ETV6, RB1, BTG1, EBF1, CDKN2A-CDKN2B, Xp22.33 acute lymphoblastic leukemia (ALL)
P335-B1 Vs. 09 18-06-2012 IKZF1, PAX5, ETV6, RB1, BTG1, EBF1, CDKN2A-CDKN2B, Xp22.33 acute lymphoblastic leukemia (ALL)
P335-B2 Vs. 19 04-07-2016 IKZF1, PAX5, ETV6, RB1, BTG1, EBF1, CDKN2A-CDKN2B, Xp22.33 acute lymphoblastic leukemia (ALL)
Vs. 01
07-12-2009
UBE3A, MTHFR, GABRB3, AXIN1 Angelman
Vs. 04
09-12-2012
UBE3A, MTHFR, GABRB3, AXIN1 Angelman
Vs. 05
11-08-2015
UBE3A, MTHFR, GABRB3, AXIN1 Angelman
Vs. 06
16-02-2016
UBE3A, MTHFR, GABRB3, AXIN1 Angelman
Vs. 07
08-11-2016
UBE3A, MTHFR, GABRB3, AXIN1 Angelman
Vs. 03
10-11-2010
TSC2 gene, 16p13.3 Tuberous sclerosis
P337-A2 Vs. 04 11-03-2012 TSC2 gene, 16p13.3 Tuberous sclerosis
P337-A2 Vs. 05 09-12-2012 TSC2 gene, 16p13.3 Tuberous sclerosis
P337-B1 Vs. 06 24-07-2014 TSC2 gene, 16p13.3 Tuberous sclerosis
P337-B1 Vs. 07 01-06-2015 TSC2 gene, 16p13.3 Tuberous sclerosis
P337-B1 Vs. 08 02-08-2016 TSC2 gene, 16p13.3 Tuberous sclerosis
P338-B1 Vs. 06 18-08-2016 GBA 1q22 Gaucher disease
P339-A1 Vs. 01 13-08-2010 SHANK3 22q13.33 Autism Spectrum Disorder
P339-A1 Vs. 04 01-03-2013 SHANK3 22q13.33 Autism Spectrum Disorder
P339-B1 Vs. 06 02-10-2015 SHANK3 22q13.33 Autism Spectrum Disorder